Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2333-2340

This Article
Right arrow Abstract Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonthu, S.
Right arrow Articles by Faraci, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonthu, S.
Right arrow Articles by Faraci, F. M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2333-2340.)
© 1997 American Heart Association, Inc.


Articles

Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice

Srinivas Bonthu; Donald D. Heistad; David A. Chappell; Kathryn G. Lamping; ; Frank M. Faraci

From the Departments of Internal Medicine and Pharmacology (D.D.H., F.M.F.), Cardiovascular Center, University of Iowa College of Medicine, Iowa City.

Correspondence to Donald D. Heistad, MD, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52242-1081.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract We examined the vascular structure and endothelium-dependent relaxation in two genetic models of hypercholesterolemia: apolipoprotein E (apoE)-knockout mice and combined apoE/LDL receptor–double-knockout mice. Intimal area was increased markedly in proximal segments of thoracic aortas from apoE/LDL receptor–knockout mice [0.13±0.03 (mean±SE) mm2] compared with normal (C57BL/6J) mice (0.002±0.002 mm2, P<.05). Despite intimal thickening, the vascular lumen was not smaller in the aortas of apoE/LDL receptor–knockout mice (0.52±0.03 mm2) than in normal mice (0.50±0.03 mm2). In apoE-deficient mice, intimal thickening was minimal or absent, even though the concentration of plasma cholesterol was only modestly less than that in the double-knockout mouse (14.9±1.1 vs 18.0±1.2 mmol/L, respectively, P<.05). Relaxation of the aorta was examined in vitro in vascular rings precontracted with U46619. In normal mice, acetylcholine produced relaxation, which was markedly attenuated by the nitric oxide synthase inhibitor NG-nitro-L-arginine (100 µM). Relaxation to acetylcholine and the calcium ionophore A23187 was normal in apoE-deficient mice (in which lesions were minimal) but greatly impaired in the proximal segments of thoracic aortas of apoE/LDL receptor–deficient mice, which contained atherosclerotic lesions. Vasorelaxation to nitroprusside was similar in normal and apoE-knockout mice, with modest but statistically significant impairment in atherosclerotic segments of apoE/LDL receptor–knockout mice. In distal segments of the thoracic aorta of apoE/LDL receptor–deficient mice, atherosclerotic lesions were minimal or absent, and the endothelium-dependent relaxation to acetylcholine and calcium ionophore was normal. Thus, in apoE/LDL receptor–knockout mice (a genetic model of hyperlipidemia), there is vascular remodeling with preservation of the aortic lumen despite marked intimal thickening, with impairment of endothelium-dependent relaxation to receptor- and nonreceptor-mediated agonists. Atherosclerosis may be accelerated in the apoE/LDL receptor–double-knockout mouse compared with the apoE-knockout strain alone. We speculate that other factors, such as the absence of LDL receptors, may contribute to the differences in the extent of atherosclerosis in these two models of hyperlipidemia.


Key Words: gene knockout • aorta • atherosclerosis • acetylcholine • hypercholesterolemia


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Previous studies of the effects of experimental atherosclerosis on vascular function have focused primarily on diet-induced atherosclerosis.1 2 3 4 Watanabe heritable hyperlipidemic rabbits, an inbred, polygenic strain that has defective LDL receptors, are the only defined genetic model of hyperlipidemia and atherosclerosis in which vascular function has been examined.5 6 7 Recently, several murine strains have been described that are genetically susceptible to atherosclerosis and thus, provide potentially valuable models to study the vascular biology of atherosclerosis.8 Atherosclerosis in mice has many features that are characteristic of lesions found in humans.8 Murine models that lack the gene encoding apoE or a combined apoE and LDL receptor knockout develop spontaneous hypercholesterolemia and atherosclerotic lesions.9 10 11 12 13 14

Atherosclerosis impairs endothelium-dependent relaxation in diet-induced experimental animal models1 2 3 4 15 and in human arteries with atherosclerosis.16 17 18 19 It is not known whether hyperlipidemia produced by selective gene knockouts is associated with vascular dysfunction. Hence, we examined the hypothesis that endothelium-dependent relaxation is impaired in two nondietary, genetic models of hypercholesterolemia: apoE-knockout and combined apoE/LDL receptor–knockout mice. To determine whether alterations in endothelium-dependent relaxation are a diffuse abnormality produced by hypercholesterolemia per se or are confined to those vessels that contain atherosclerotic lesions, we compared responses of the proximal (atherosclerotic) and distal segments of the thoracic aorta, where intimal thickening was minimal or absent. Our goal was to examine vascular responses in genetic models of atherosclerosis. We examined vascular responses in two animal models that have different degrees of atherosclerosis.

Finally, we examined structural changes in the atherosclerotic aorta to determine whether vascular "remodeling" had occurred. In remodeling during atherosclerosis, intimal thickening is associated with outward displacement of the vessel wall so that the vascular lumen is relatively preserved.20 21 22 Vascular remodeling has been observed in diet-induced atherosclerosis in experimental animals and in coronary arteries of humans with atherosclerosis20 21 22 but has not been described in a genetic model of atherosclerosis.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Procedures used in these experiments were approved by the University of Iowa Animal Care and Use Preview Committee. We studied C57BL/6J (normal), homozygous apoE–deficient, and double-homozygous apoE and LDL receptor–deficient mice that were third- or fourth-generation hybrids (with a 129xC57BL/6J background) from the colony at The Jackson Laboratory, Bar Harbor, ME. The lines were derived from brother-sister matings using knockout animals initially created by homologous recombination in embryonic stem cells. Male and female mice were fed regular mouse chow and water ad libitum. The ages (in weeks) of normal, apoE-deficient, and apoE/LDL receptor–deficient mice were 16±1, 19±3, and 19±1 and the weights (in grams) were 25±1, 30±2, and 31±1, respectively. Plasma cholesterol levels in whole plasma and fast protein liquid chromatography fractions were determined by colorimetric enzymatic assays (Boehringer Mannheim kit No. 126012) in 96-well microplates. After an overnight fast, 100 µL of mouse plasma was withdrawn, fractionated on a Superose 6 column (Pharmacia) with 10 mmol/L Tris-buffered saline (pH 8.0), pumped at 0.5 mL/min, and collected in 0.5-mL fractions as described previously.23

Vascular Ring Preparation
Studies were performed on aortic rings in vitro. On the day of the study, the mouse was anesthetized with sodium pentobarbital injection (0.2 mg/g body weight), and the thoracic aorta was removed and immediately placed in Krebs' buffer of the following ionic composition (mmol/L): NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25, and glucose 12. Loose connective tissue in the adventitia was removed carefully to avoid damage to the endothelial surface, and the vessel was cut into rings (3 to 4 mm long) from the ascending aorta and distal thoracic aorta. Typically, four rings per mouse were studied. Aortic rings were mounted on stainless steel hooks and suspended in vertical organ baths containing 25 mL Krebs' solution maintained at 37°C and aerated with a mixture of 95% O2 and 5% CO2. The rings were connected to force transducers to measure isometric tension. Resting tension was gradually increased to reach the final tension of 0.5 g, and the rings were allowed to equilibrate for at least 90 minutes and washed at 20-minute intervals. The rings were left at this optimal resting tension throughout the remainder of the study.

Protocols
Aortic segments were precontracted by using a thromboxane analogue [U46619 (9,11-dideoxy-11a,9a-epoxy-methanoprostaglandin F2{alpha})]. After stabilization at submaximal contraction (~50% of maximum), responses to cumulative concentrations of acetylcholine and nitroprusside were tested both in the presence and absence of an inhibitor of nitric oxide synthase L-NNA (100 µmol). Responses to cumulative concentrations of calcium ionophore A23187 were also studied. Between each concentration-response curve, the vessels were washed at least three times with fresh Krebs' buffer and allowed to reequilibrate.

To evaluate a possible contribution of superoxide anion radicals to endothelial dysfunction, we studied responses to acetylcholine and nitroprusside in the presence of SOD (100 U/mL). We also studied responses to acetylcholine in the aorta from apoE/LDL receptor–deficient mice that had been injected with PEG-SOD for 5 days (50 U · g-1 · d-1).3

Drugs
Acetylcholine, sodium nitroprusside, L-NNA, SOD, U46619, and calcium ionophore A23187 were obtained from Sigma Chemical Co. Stock solution (1 mmol) of A23187 was prepared by dissolving the drug in 50% DMSO and 50% isotonic saline. Stock solution of U46619 was prepared by dissolving it in ethanol, and subsequent dilutions were made in isotonic saline. All other drugs were dissolved and diluted in isotonic saline. All concentrations are expressed as the final concentration of each drug in the organ bath.

Assessment of Atherosclerosis
After completion of the experiment, proximal and distal segments of thoracic aorta were fixed in formalin, and 8- to 10-µm sections were cut and stained with Verhoeff–Van Gieson's, and hematoxylin/eosin stains. We obtained five rings from anatomically constant sites: one from the midpoint of the ascending aorta ({approx}2 mm from the aortic valve), one from the midaortic arch (midway between the innominate and left carotid artery), and three rings from the descending thoracic aorta ({approx}1, 4, and 7 mm from the distal to the subclavian artery). Four of the five rings (excluding the one from the midaortic arch) that were used for morphometry were also used for studies of vascular reactivity. For morphometry, we obtained samples from normal (n=17), apoE-knockout (n=15), and apoE/LDL receptor–knockout (n=28) mice. Morphometric (quantitative) determination of the size of the intima and media was performed with an image analyzer as described previously.20 24 In brief, the cross-sectional areas of the intima and media were projected and digitized. To determine the luminal area, the cross-sectional area enclosed by the internal elastic lamina was corrected to a circle by applying the form factor l2/4{pi} to the measurement of the internal elastic lamina, where l is the length of the lamina; the luminal area was calculated as the difference between the corrected area within the internal elastic lamina and the intimal area.

Statistical Analysis
All data are expressed as mean±SE; n indicates the number of animals. Relaxation responses to acetylcholine, A23187, and sodium nitroprusside were expressed as the percent relaxation from the amount of precontraction produced by U46619. The response was recorded as the cumulative relaxation response at each dose, expressed as a percentage of the initial precontraction tension. The EC50 values were calculated by using a computer program that assumes a linear curve between two points around 50% of the maximum response. Comparisons were made using either a paired or unpaired Student's t test. The Bonferroni correction was used for multiple comparisons. Statistical significance was accepted at P<.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
The average plasma cholesterol levels in normal (C57BL/6J), apoE-deficient, and combined apoE/LDL receptor–deficient mice were 2.8±0.2 mmol/L (n=17), 14.9±1.1 mmol/L (n=26) (P<.05 versus normal), and 18.0±1.2 mmol/L (n=26) (P<0.05 versus normal and apoE deficient), respectively. Fig 1Down shows the cholesterol profile for normal, apoE-deficient, and apoE/LDL receptor–deficient mice. As expected from previously published studies,12 normal mice do not have prominent cholesterol-containing particles in the VLDL and LDL density ranges. Their most prominent peak is in the HDL range near fraction 35. In contrast, apoE-deficient mice have a prominent peak in the largest particles near fraction 20. ApoE/LDL receptor–deficient mice have an additional large peak in the LDL range around fraction 28.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 1. Fractionation by fast protein liquid chromatography (Superose 6) of plasma lipoproteins from control ({bullet}), apoE-knockout ({square}), and combined apoE/LDL receptor–knockout ({bigtriangleup}) mice that were fed a normal diet.

Morphometry and Histology
There was marked thickening of the intima-media of the proximal (ascending) aorta of apoE/LDL receptor–deficient mice, and minimal (size) atherosclerotic lesions of the proximal (ascending) thoracic aorta from apoE-deficient mice (Figs 2Down and 3Down). No intimal thickening or lesions were observed in the aortas of normal mice (Fig 3Down). Despite intimal thickening in apoE/LDL receptor–knockout mice and marked differences in the severity of atherosclerosis, the area of the lumen was similar in the proximal thoracic aortas from normal, apoE-deficient, and atherosclerotic apoE/LDL receptor–deficient mice (Fig 3Down).



View larger version (107K):
[in this window]
[in a new window]
 
Figure 2. Cross section of proximal segments of thoracic aortas from a wild-type control (A) mouse and three different apoE/LDL receptor–knockout mice (B, C, and D). Marked intimal thickening was present in the double-knockout mice (B through D).



View larger version (10K):
[in this window]
[in a new window]
 
Figure 3. Area of the intima-media (left) and lumen (right) in proximal segments of thoracic aortas from wild-type (normal, n=17), apoE-knockout (ApoE-, n=15), and combined apoE/LDL receptor–knockout (ApoE-/LDLr-, n=28) mice. Values are mean±SE. *P<.05 vs control.

There were minimal or no atherosclerotic lesions in the distal segments of thoracic aortas from apoE/LDL receptor–knockout mice. The area of the vascular lumen was similar in distal segments of thoracic aortas of normal (0.38±0.02 mm2), apoE-knockout (0.42± 0.03 mm2), and apoE/LDL receptor–knockout (0.36±0.02 mm2) mice.

Responses to U46619
The optimal resting tension in all groups of mice was 0.5 g. The maximal response to U46619 was 1.41±0.05 g in the normal aortas, similar in aortas from apoE-deficient mice, and smaller in the proximal segments of thoracic aortas of apoE/LDL receptor–deficient mice (0.92±0.08 g, P<.05). The EC50 for contraction with U46619 was -7.74±0.06 in normal mice and was not significantly different in vessels from apoE-deficient or apoE/LDL receptor–deficient mice.

Responses in Normal C57BL/6J Mice
In vessels from normal mice, acetylcholine produced concentration-dependent relaxation (Fig 4Down), and the response was similar in both proximal and distal segments of the thoracic aorta (Fig 5Down). Relaxation to acetylcholine was similar in female and male mice (data not shown). Relaxation to A23187 and nitroprusside was also similar in proximal and distal segments of thoracic aortas of normal mice (Fig 5Down).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 4. Relaxation of the proximal segments of thoracic aortas in response to acetylcholine (Ach) and nitropussicide (NP) in wild-type (normal) (upper trace) and apoE/LDL receptor–knockout (lower trace) mice. Aortic rings were precontracted submaximally with U46619 prior to application of acetycholine. Concentrations of acetylcholine in -log mol/L are given above each tracing.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 5. Relaxation of the proximal and distal segments of thoracic aortas in response to acetylcholine (left, n=6), A23187 (middle, n=4), and sodium nitroprusside (right, n=6) in control (wild-type) mice. Values are mean±SE.

In normal mice, relaxation to acetylcholine was markedly attenuated by L-NNA (100 µmol), a nitric oxide synthase inhibitor (P<.05). Maximum relaxation in response to acetylcholine was 76±5% and 38±4% in the absence and presence of L-NNA, respectively. L-NNA did not inhibit but instead enhanced (produced a leftward shift of the dose-response curve) responses to sodium nitroprusside in the normal mouse aorta (P<.05). The EC50 for nitroprusside was -7.62±0.13 and -8.24±0.10 in the absence and presence of L-NNA, respectively.

Responses in ApoE-Knockout Mice
In apoE-knockout mice, relaxation in response to acetylcholine and nitroprusside in the proximal segments of the thoracic aorta, which had minimal or no intimal thickening, was similar to that of the distal segments of the thoracic aorta (Fig 6Down). Relaxation was similar to that in normal mice (Fig 5Up). The EC50 for relaxation with acetylcholine and nitroprusside was similar in the aortas of normal and apoE-deficient mice (TableDown).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 6. Relaxation of the proximal and distal segments of thoracic aortas in response to acetylcholine (left, n=6) and sodium nitroprusside (right, n=5) in apoE-knockout mice. Values are mean±SE.


View this table:
[in this window]
[in a new window]
 
Table 1. Relaxation of the Aorta in Response to Acetylcholine and Nitroprusside

Relaxation to acetylcholine was markedly attenuated by L-NNA in apoE-deficient mice (data not shown). Thus, vasorelaxation in response to acetylcholine was mediated by nitric oxide in apoE-knockout mice as well as in normal mice. Similar to its effects on the normal aorta, L-NNA enhanced the response to sodium nitroprusside in aortas of apoE-knockout mice (data not shown).

Responses in ApoE/LDL Receptor–Double-Knockout Mice
In apoE/LDL receptor–mutant mice, relaxation to acetylcholine was markedly impaired in the proximal segments of the thoracic aorta, which had atherosclerotic lesions when compared with the distal segments of thoracic aorta, which had minimal or no intimal thickening (Figs 4Up and 7Down). In response to acetylcholine, relaxation of proximal segments of thoracic aortas of apoE/LDL receptor–knockout mice was significantly impaired when compared with proximal segments of thoracic aortas of either normal or apoE-knockout mice (Figs 4 through 6UpUpUp). Impairment of relaxation to acetylcholine in the proximal thoracic aorta of apoE/LDL receptor–knockout mice was similar in female and male mice (data not shown). Relaxation of the proximal (atherosclerotic) segments of the thoracic aorta in response to A23187 was markedly impaired compared with distal segments of the thoracic aorta of apoE/LDL receptor–deficient mice or normal mice (Fig 7Down).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 7. Relaxation of the proximal (n=13) and distal (n=8) segments of thoracic aortas in response to acetylcholine (left), A23187 (middle, n=4 for both segments), and sodium nitroprusside (right, n=11 proximal and n=8 distal) in apoE/LDL receptor–deficient mice. Values are mean±SE. Relaxation of the proximal segments of thoracic aortas in response to acetylcholine (left) was significantly less (P<.05) than that of the distal segments of the thoracic aorta at concentrations of acetylcholine of >=10-7 mol/L. Relaxation of the proximal segments of thoracic aortas in response to A23187 (middle) was significantly less (P<.05) than that of the distal segments of thoracic aorta at 3x10-7 and 10-6 mmol/L A23187. Relaxation of the proximal segments of thoracic aorta in response to nitroprusside (right) was significantly less (P<.05) than that of the distal segments of thoracic aorta at concentrations of nitroprusside >=10-7 mol/L.

In the proximal (atherosclerotic) segments of thoracic aortas of apoE/LDL receptor–deficient mice, relaxation in response to sodium nitroprusside was attenuated (Fig 7Up). Relaxation to sodium nitroprusside in distal segments of thoracic aortas of apoE/LDL receptor–knockout mice was similar to that of normal and apoE-deficient mice. The EC50 for relaxation in response to sodium nitroprusside was similar in all three groups of mice (data not shown).

As in normal and apoE-deficient mice, relaxation of the distal segments of thoracic aortas in response to acetylcholine was markedly attenuated in the presence of L-NNA in apoE/LDL receptor–knockout mice. L-NNA did not inhibit but enhanced (produced a leftward shift of the dose-response curve) responses to sodium nitroprusside in both normal and atherosclerotic segments of thoracic aortas (data not shown).

Effect of SOD
In vitro incubation of the atherosclerotic segments of thoracic aortas from apoE/LDL receptor–deficient mice with SOD (100 U/mL) for 30 minutes did not significantly influence endothelium-dependent relaxation (maximum relaxation in response to acetylcholine, 33±7%). In apoE/LDL receptor–deficient mice (n=3) injected with PEG-SOD (for 5 days), relaxation of the proximal atherosclerotic segments of the thoracic aorta in response to acetylcholine (maximum relaxation in response to acetylcholine, 12±7%) was not improved.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Endothelium-dependent relaxation is impaired by atherosclerosis in humans and in several animal models of atherosclerosis.15 This is the first study to examine vascular function in hyperlipidemic mice with well-defined genetic defects. The major new findings in this study are that in the presence of atherosclerotic lesions, there is vascular remodeling and impairment of relaxation to receptor- and nonreceptor-mediated endothelium-dependent agonists (acetylcholine and A23187). The defect in endothelium-dependent relaxation observed in the proximal atherosclerotic segments of thoracic aortas of apoE/LDL receptor–knockout mice apparently was not produced by hypercholesterolemia per se, because the distal segments of the thoracic aorta (which had minimal or no intimal thickening) of the same mouse relaxed normally in response to both acetylcholine and A23187.

Endothelium-Dependent Relaxation
There have been few studies that have examined endothelium-dependent relaxation of mouse vessels in vitro. In normal mice, we found that acetylcholine produced relaxation that was markedly attenuated by the nitric oxide synthase inhibitor L-NNA. Thus, relaxation of the normal mouse aorta in response to acetylcholine is mediated in large part by nitric oxide.

Mechanisms that produce impaired endothelial function in atherosclerosis are not completely clear. One possibility is that smaller quantities of nitric oxide are produced by atherosclerotic vessels in response to endothelium-dependent stimuli. This seems unlikely, because levels of mRNA and protein for the endothelial isoform of nitric oxide synthase (NOS III) and the production of nitric oxide in the atherosclerotic rabbit aorta appear to be increased rather than decreased.25 26 We found that vasorelaxation in response to both acetylcholine and A23187 was impaired in the proximal aortas of apoE/LDL receptor–deficient mice, which contained atherosclerotic lesions. Impairment of responses to A23187 suggests that endothelial dysfunction extends beyond muscarinic receptors in this genetic model.

A second possible mechanism of impairment of endothelial function relates to degradation and/or inactivation of nitric oxide by superoxide anion. Incorporation of lipids within the endothelium, an early manifestation of atherosclerosis, and associated oxidative processes may be responsible for the degradation of nitric oxide. For example, increased production of superoxide anion in atherosclerotic arteries has been detected in several studies.4 27 28 Nitric oxide is rapidly inactivated by superoxide anion.29 30 The reaction of nitric oxide and superoxide anion occurs even more rapidly than the reaction of superoxide anion with SOD.29 30

A third possibility is impaired response of vascular muscle to nitric oxide. Relatively normal relaxation in response to sodium nitroprusside in normal and atherosclerotic vessels suggests that the guanylate cyclase/cGMP system is intact in vascular muscle. The slightly diminished relaxation of atherosclerotic segments of thoracic aortas from apoE/LDL receptor–deficient mice in response to sodium nitroprusside may be attributed to the severity of the lesion.

Some3 5 31 but not all32 33 studies have shown that impaired endothelium-dependent responses during hypercholesterolemia and/or atherosclerosis can be restored toward normal by SOD. In the present study, endothelium-dependent relaxation of the proximal atherosclerotic segments of thoracic aortas of apoE/LDL receptor–deficient mice was not improved by acute or chronic (5-day) treatment with SOD. We cannot exclude the possibility that the dose or duration of SOD administration was not sufficient. Nevertheless, this finding is similar to that in a recent study in patients32 and suggests that either generation of superoxide anion is not important in this model or that exogenously administered SOD may be unable to reach the site of formation of superoxide anion. Because of the extremely efficient reaction of superoxide anion and nitric oxide,29 30 SOD needs to be present at the site of superoxide radical generation to protect nitric oxide.30 Thus, our studies do not exclude a role for enhanced generation of superoxide anion as a mediator of vascular dysfunction during atherosclerosis.

We found that responses to acetylcholine did not differ in female and male mice. This finding in normal and atherosclerotic mice is different from previous reports in other species.34 35 36 37 38 It is possible that our observation is an artifact, because the number of females and males in each group was small. It is possible, however, that the finding is accurate for mice. In monkeys and rabbits, estrogen modulates vasomotion of atherosclerotic coronary arteries.35 36 Other studies indicate that in C57BL/6J mice, males are more resistant than females to hypercholesterolemia-induced atherosclerosis.39 A recent study demonstrated that basal release of endothelium-derived nitric oxide was significantly greater in the aortas of male (C57BL/6J) than in female mice.40 Thus, findings in previous studies39 40 and the present study may suggest that increased susceptibility to atherosclerosis in males, which is characteristic of several species, is not observed in C57BL/6J mice.

Severity of Atherosclerosis
A surprising finding in the present study is that intimal thickening in the proximal segments of the thoracic aorta was much greater in apoE/LDL receptor–knockout mice than in apoE-knockout mice. We used mice that were <20 weeks old, and our findings with apoE-knockout mice are consistent with previous studies, which observed only modest atherosclerosis in apoE-knockout mice that were <20 weeks of age.9 10 In older apoE-knockout mice fed a normal diet, extensive atherosclerosis develops in the proximal segments of the thoracic aorta.9 10 11 To our knowledge, similar studies have not been performed previously in combined apoE/LDL receptor–knockout mice. Plasma cholesterol levels were only modestly greater in apoE/LDL receptor–knockout mice (18.0 mmol/L) than in apoE-knockout mice (14.9 mmol/L), which is consistent with previous studies by Ishibashi et al.12 Thus, it was surprising that intimal thickening was {approx}12-fold greater in the double-knockout than the apoE-knockout mice.

A possible explanation for the marked difference in development of atherosclerosis in apoE/LDL receptor–knockout mice compared with apoE-knockout mice is the presence of a prominent population of cholesterol-rich LDL in apoE/LDL receptor–knockout mice. Larger cholesterol-rich particles, which are known to resemble ß-VLDL, predominate in both hyperlipidemic models. However, LDLs are smaller than ß-VLDLs and consequently are more likely to penetrate the endothelium and deposit in the arterial wall. Another possibility is that the absence per se of LDL receptors in the vessels is atherogenic. The role of vascular LDL receptors in atherosclerosis is unclear. LDL catabolism by the intima has been shown to be predominant.34

The observation of vascular remodeling in atherosclerotic apoE/LDL receptor–knockout mice is of interest. Several pathological processes in the intima-media of atherosclerotic arteries result in thickening of the vessel wall. In remodeling, the atherosclerotic vessel wall thickens, but there is outward displacement of the vessel wall so that the lumen is preserved. The area circumscribed by the internal elastic lamina increases as the area of the plaque contained within the lumen increases. In studies of atherosclerosis in nonhuman primates and in atherosclerotic human coronary arteries, maintenance of lumen size has been noted despite massive intimal thickening.20 21 22 Vascular remodeling is thought to require synthesis and reorganization of collagen and the extracellular matrix. Our observations indicate that the apoE/LDL receptor–knockout mouse may be a useful model for future studies of this process.

In summary, the present study shows that atherosclerosis, which is more severe in combined apoE/LDL receptor–knockout mice than in apoE-knockout mice, is associated with vascular remodeling and significant attenuation of the endothelial regulation of vascular tone. These studies of endothelial function in mice provide the foundation for additional studies of vascular biology in novel, genetically altered models.


*    Selected Abbreviations and Acronyms
 
Ach = acetylcholine
apoE = apolipoprotein E
L-NNA = NG-nitro-L-arginine
PEG-SOD = polyethylene-glycolated SOD
(S)NP = (sodium) nitroprusside


*    Acknowledgments
 
This work was supported by National Institutes of Health grants HL-14388 (to D.D.H.), HL-38901 (to F.M.F.), HL-16066 and AG-10269 (to D.D.H.)., HL-39050 (to K.G.L.), and HL-49264 (to D.A.C.) and by research funds from the Veterans Administration. Kathryn G. Lamping and Frank M. Faraci are Established Investigators of the American Heart Association. We thank Kristen Rummelhart for technical assistance.

Received November 4, 1996; accepted June 16, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest.. 1987;79:170-174.

2. Freiman PC, Mitchell GC, Heistad DD, Armstrong ML, Harrison DG. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res.. 1986;58:783-789.[Abstract/Free Full Text]

3. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res.. 1991;69:1293-1300.[Abstract/Free Full Text]

4. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest.. 1993;91:2546-2551.

5. Tagawa H, Tomoike H, Nakamura M. Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ Res.. 1991;68:330-337.[Abstract/Free Full Text]

6. Taguchi H, Faraci FM, Kitazono T, Heistad DD. Relaxation of the carotid artery to hypoxia is impaired in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol.. 1995;15:1641-1645.[Abstract/Free Full Text]

7. Tagawa H, Tomoike H, Nakamura M. Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ Res.. 1991;68:330-337.

8. Breslow JL. Mouse models of atherosclerosis. Science. 1996;272:685-688.[Abstract]

9. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb.. 1994;14:133-140.[Abstract/Free Full Text]

10. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E: evaluation of lesional development and progression. Arterioscler Thromb.. 1994;14:141-147.[Abstract/Free Full Text]

11. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb.. 1994;14:605-616.[Abstract/Free Full Text]

12. Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A.. 1994;91:4431-4435.[Abstract/Free Full Text]

13. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res.. 1995;36:2320-2328.[Abstract]

14. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.[Medline] [Order article via Infotrieve]

15. Busse R, Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res.. 1996;33:181-194.[Medline] [Order article via Infotrieve]

16. Ludmer PL, Selwyn AP, Shook TL, Wayne RR. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med.. 1986;315:1046-1051.[Abstract]

17. Liao JK, Bettmann MA, Sandor T, Tucker JI, Coleman SM, Creager MA. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res.. 1991;68:1027-1034.[Abstract/Free Full Text]

18. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 1990;336:897-900.[Medline] [Order article via Infotrieve]

19. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest.. 1993;92:652-662.

20. Armstrong ML, Heistad DD, Marcus ML, Megan MB, Piegors DJ. Structural and hemodynamic responses of peripheral arteries of macaque monkeys to atherogenic diet. Arteriosclerosis. 1985;5:336-346.[Abstract/Free Full Text]

21. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med.. 1987;316:1371-1375.[Abstract]

22. Di Marion C, Ruygrok PN, Serruys PW. Vascular remodeling in coronary artery disease. J Cardiovasc Pharmacol. 1994;24(suppl 3):S5–S15.

23. De Silva HV, Mas-Oliva J, Taylor JM, Mahley RW. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J Lipid Res.. 1994;35:1297-1310.[Abstract]

24. Sobey CG, Faraci FM, Piegors DJ, Heistad DD. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries. Stroke.. 1996;27:927-933.[Abstract/Free Full Text]

25. Kanazawa K, Kawashima S, Mikami S, Miwa Y, Hirata K, Suematsu M, Hayashi Y, Itoh H, Yokoyama M. Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol.. 1996;148:1949-1956.[Abstract]

26. Minor R, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases release of nitrogen oxides from rabbit aorta. J Clin Invest.. 1990;86:2109-2116.

27. Mugge A, Brandes RP, Boger RH, Dwenger A, Bode-Boger S, Kienke S, Frolich JC, Lichtlen PR. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol.. 1994;24:994-998.[Medline] [Order article via Infotrieve]

28. Boger RH, Bode-Boger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995;117:273-284.[Medline] [Order article via Infotrieve]

29. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A.. 1990;87:1620-1624.[Abstract/Free Full Text]

30. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett.. 1995;369:131-135.[Medline] [Order article via Infotrieve]

31. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A.. 1994;91:1044-1048.[Abstract/Free Full Text]

32. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO, Quyyumi AA, Panza JA. Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol.. 1995;76:1157-1161.[Medline] [Order article via Infotrieve]

33. Kamata K, Kojima S, Sugiura M, Kasuya Y. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed mice by the chronic administration of prazosin or pravastatin. Jpn J Pharmacol.. 1996;70:149-156.[Medline] [Order article via Infotrieve]

34. Carew TE, Pittman RC, Marchand ER, Steinberg D. Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta: predominance of intimal degradation. Arteriosclerosis.. 1984;4:214-224.[Abstract/Free Full Text]

35. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation.. 1990;81:1680-1687.[Abstract/Free Full Text]

36. Hayashi T, Fukoto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A.. 1992;89:11259-11263.[Abstract/Free Full Text]

37. Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol.. 1994;267:H2311–H2317.[Abstract/Free Full Text]

38. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation.. 1994;89:1501-1510.[Abstract/Free Full Text]

39. Paigen B, Holmes PA, Mitchell D, Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female and testosterone-treated female mice from steroid C57BL/b, BALB/c, and C34. Atherosclerosis.. 1987;64:215-221.[Medline] [Order article via Infotrieve]

40. Rubanyi BM, Freat AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. J Clin Invest.. 1997;99:2429-2437.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
J. Physiol.Home page
J. R. Durrant, D. R. Seals, M. L. Connell, M. J. Russell, B. R. Lawson, B. J. Folian, A. J. Donato, and L. A. Lesniewski
Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase
J. Physiol., July 1, 2009; 587(13): 3271 - 3285.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. B. Anea, M. Zhang, D. W. Stepp, G. B. Simkins, G. Reed, D. J. Fulton, and R. D. Rudic
Vascular Disease in Mice With a Dysfunctional Circadian Clock
Circulation, March 24, 2009; 119(11): 1510 - 1517.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. W. Nuno, V. P. Korovkina, S. K. England, and K. G. Lamping
RhoA Activation Contributes to Sex Differences in Vascular Contractions
Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 1934 - 1940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. A. Stapleton, Adam. G. Goodwill, M. E. James, and J. C. Frisbee
Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1110 - R1119.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. A. Korshunov, S. M. Schwartz, and B. C. Berk
Vascular Remodeling: Hemodynamic and Biochemical Mechanisms Underlying Glagov's Phenomenon
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1722 - 1728.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Kitayama, F. M. Faraci, S. R. Lentz, and D. D. Heistad
Cerebral Vascular Dysfunction During Hypercholesterolemia
Stroke, July 1, 2007; 38(7): 2136 - 2141.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Rahmani, R. P. Cruz, D. J. Granville, and B. M. McManus
Allograft Vasculopathy Versus Atherosclerosis
Circ. Res., October 13, 2006; 99(8): 801 - 815.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Ohashi, M. S. Runge, F. M. Faraci, and D. D. Heistad
MnSOD Deficiency Increases Endothelial Dysfunction in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2331 - 2336.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Lorkowska, M. Bartus, M. Franczyk, R. B. Kostogrys, J. Jawien, P. M. Pisulewski, and S. Chlopicki
Hypercholesterolemia Does Not Alter Endothelial Function in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1019 - 1026.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. Gigante, G. Morlino, M. T. Gentile, M. G. Persico, and S. De Falco
Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia
FASEB J, May 1, 2006; 20(7): 970 - 972.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
T. Godfraind
Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis
Phil Trans R Soc B, December 29, 2005; 360(1464): 2259 - 2272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Kyselovic, P. Martinka, Z. Batova, A. Gazova, and T. Godfraind
Calcium Channel Blocker Inhibits Western-Type Diet-Evoked Atherosclerosis Development in ApoE-Deficient Mice
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 320 - 328.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. G. Lamping, J. Wess, Y. Cui, D. W. Nuno, and F. M. Faraci
Muscarinic (M) Receptors in Coronary Circulation: Gene-Targeted Mice Define the Role of M2 and M3 Receptors in Response to Acetylcholine
Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1253 - 1258.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. G. Frank, S. E. Woodman, D. S. Park, and M. P. Lisanti
Caveolin, Caveolae, and Endothelial Cell Function
Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1161 - 1168.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. M. Crauwels, C. E. Van Hove, P. Holvoet, A. G. Herman, and H. Bult
Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI
Cardiovasc Res, July 1, 2003; 59(1): 189 - 199.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Pelat, C. Dessy, P. Massion, J.-P. Desager, O. Feron, and J.-L. Balligand
Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide-Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E-/- Mice In Vivo
Circulation, May 20, 2003; 107(19): 2480 - 2486.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. de Nigris, L. O. Lerman, S. W. Ignarro, G. Sica, A. Lerman, W. Palinski, L. J. Ignarro, and C. Napoli
From the Cover: Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress
PNAS, February 4, 2003; 100(3): 1420 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Gervais, S. Pons, A. Nicoletti, C. Cosson, J.-F. Giudicelli, and C. Richer
Fluvastatin Prevents Renal Dysfunction and Vascular NO Deficit in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 183 - 189.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. F. Bentzon, G. Pasterkamp, and E. Falk
Expansive Remodeling Is a Response of the Plaque-Related Vessel Wall in Aortic Roots of ApoE-Deficient Mice: An Experiment of Nature
Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 257 - 262.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. P. Didion, M. J. Ryan, L. A. Didion, P. E. Fegan, C. D. Sigmund, and F. M. Faraci
Increased Superoxide and Vascular Dysfunction in CuZnSOD-Deficient Mice
Circ. Res., November 15, 2002; 91(10): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Didion, M. J. Ryan, G. L. Baumbach, C. D. Sigmund, and F. M. Faraci
Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1569 - H1576.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Chu, D. D. Heistad, K. L. Knudtson, K. G. Lamping, and F. M. Faraci
Quantification of mRNA for Endothelial NO Synthase in Mouse Blood Vessels by Real-Time Polymerase Chain Reaction
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 611 - 616.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. V d'Uscio, M. Barton, S. Shaw, and T. F Luscher
Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice
Cardiovasc Res, February 1, 2002; 53(2): 487 - 495.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. J. Ryan, S. P. Didion, D. R. Davis, F. M. Faraci, and C. D. Sigmund
Endothelial Dysfunction and Blood Pressure Variability in Selected Inbred Mouse Strains
Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Godecke, M. Ziegler, Z. Ding, and J. Schrader
Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms
Cardiovasc Res, January 1, 2002; 53(1): 253 - 262.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. V. d'Uscio, L. A. Smith, and Z. S. Katusic
Hypercholesterolemia Impairs Endothelium-Dependent Relaxations in Common Carotid Arteries of Apolipoprotein E-Deficient Mice
Stroke, November 1, 2001; 32(11): 2658 - 2664.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Lutgens, E. D. de Muinck, S. Heeneman, and M. J.A.P. Daemen
Compensatory Enlargement and Stenosis Develop in ApoE-/- and ApoE*3-Leiden Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1359 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. V. d'Uscio, T. A. Baker, C. B. Mantilla, L. Smith, D. Weiler, G. C. Sieck, and Z. S. Katusic
Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1017 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Darblade, D. Caillaud, M. Poirot, M.-J. Fouque, J.-C. Thiers, J. Rami, F. Bayard, and J.-F. Arnal
Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta
Cardiovasc Res, June 1, 2001; 50(3): 566 - 576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Hartley, A. K. Reddy, S. Madala, B. Martin-McNulty, R. Vergona, M. E. Sullivan, M. Halks-Miller, G. E. Taffet, L. H. Michael, M. L. Entman, et al.
Hemodynamic changes in apolipoprotein E-knockout mice
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2326 - H2334.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. G. Lamping, D. W. Nuno, E. G. Shesely, N. Maeda, and F. M. Faraci
Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1906 - H1912.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. R. Lentz, R. A. Erger, S. Dayal, N. Maeda, M. R. Malinow, D. D. Heistad, and F. M. Faraci
Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta -synthase-deficient mice
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H970 - H975.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Liuba, P. Karnani, E. Pesonen, I. Paakkari, A. Forslid, L. Johansson, K. Persson, T. Wadstrom, and R. Laurini
Endothelial Dysfunction After Repeated Chlamydia pneumoniae Infection in Apolipoprotein E-Knockout Mice
Circulation, August 29, 2000; 102(9): 1039 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kauser, V. da Cunha, R. Fitch, C. Mallari, and G. M. Rubanyi
Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice
Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1679 - H1685.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. J. Williams, R. Scalia, K. D. Mazany, W. V. Rodrigueza, and A. M. Lefer
Rapid Restoration of Normal Endothelial Functions in Genetically Hyperlipidemic Mice by a Synthetic Mediator of Reverse Lipid Transport
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1033 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Hamasaki, S. T. Higano, J. A. Suwaidi, R. A. Nishimura, K. Miyauchi, D. R. Holmes Jr, and A. Lerman
Cholesterol-Lowering Treatment Is Associated With Improvement in Coronary Vascular Remodeling and Endothelial Function in Patients With Normal or Mildly Diseased Coronary Arteries
Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 737 - 743.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. P. Didion, C. D. Sigmund, F. M. Faraci, and Z. S. Katusic
Impaired Endothelial Function in Transgenic Mice Expressing Both Human Renin and Human Angiotensinogen • Editorial Comment
Stroke, March 1, 2000; 31(3): 760 - 765.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. M. Faraci and C. D. Sigmund
Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight
Circ. Res., December 3, 1999; 85(12): 1214 - 1225.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Yang, L. Powell-Braxton, A. K. Ogaoawara, N. Dybdal, S. Bunting, O. Ohneda, and H. Jin
Hypertension and Endothelial Dysfunction in Apolipoprotein E Knockout Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2762 - 2768.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. A. Gunnett, D. J. Berg, F. M. Faraci, and G. Feuerstein
Vascular Effects of Lipopolysaccharide Are Enhanced in Interleukin-10-Deficient Mice • Editorial Comment
Stroke, October 1, 1999; 30(10): 2191 - 2196.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. de las Heras, P. Aragoncillo, R. Maeso, S. Vazquez-Perez, J. Navarro-Cid, M. DeGasparo, J. Mann, L. M. Ruilope, V. Cachofeiro, and V. Lahera
AT1 Receptor Antagonism Reduces Endothelial Dysfunction and Intimal Thickening in Atherosclerotic Rabbits
Hypertension, October 1, 1999; 34(4): 969 - 975.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Deckert, G. Lizard, N. Duverger, A. Athias, V. Palleau, F. Emmanuel, M. Moisant, P. Gambert, C. Lallemant, and L. Lagrost
Impairment of Endothelium-Dependent Arterial Relaxation By High-Fat Feeding in ApoE-Deficient Mice : Toward Normalization By Human ApoA-I Expression
Circulation, September 14, 1999; 100(11): 1230 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Caligiuri, B. Levy, J. Pernow, P. Thoren, and G. K. Hansson
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
PNAS, June 8, 1999; 96(12): 6920 - 6924.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. G. Lamping, D. W. Nuno, D. A. Chappell, and F. M. Faraci
Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1023 - R1029.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Barton, C. C. Haudenschild, L. V. d'Uscio, S. Shaw, K. Munter, and T. F. Luscher
Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice
PNAS, November 24, 1998; 95(24): 14367 - 14372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Gunnett, Y. Chu, D. D. Heistad, A. Loihl, and F. M. Faraci
Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H416 - H421.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Carmeliet, L. Moons, and D. Collen
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis
Cardiovasc Res, July 1, 1998; 39(1): 8 - 33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. M. Faraci, C. D. Sigmund, E. G. Shesely, N. Maeda, and D. D. Heistad
Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase
Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H564 - H570.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Dayal, T. Bottiglieri, E. Arning, N. Maeda, M. R. Malinow, C. D. Sigmund, D. D. Heistad, F. M. Faraci, and S. R. Lentz
Endothelial Dysfunction and Elevation of S-Adenosylhomocysteine in Cystathionine {beta}-Synthase-Deficient Mice
Circ. Res., June 8, 2001; 88(11): 1203 - 1209.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Chu, D. D. Heistad, K. L. Knudtson, K. G. Lamping, and F. M. Faraci
Quantification of mRNA for Endothelial NO Synthase in Mouse Blood Vessels by Real-Time Polymerase Chain Reaction
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 611 - 616.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonthu, S.
Right arrow Articles by Faraci, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonthu, S.
Right arrow Articles by Faraci, F. M.